Published on Mar 04, 2023
https://aegismedicalgroup.com/covid-19-testing/ : The Aegis Results Web Portal is a secure web site where Aegis clients can view, download and print laboratory reports. The portal will provide a history of all samples submitted to the laboratory within the past 30 days.
It will also allow the user to search for reports or specific samples based on a variety of options (for example: case number, date collected, laboratory ID, etc.).
Login Open your internet browser1 and enter the URL https://labonline.aegislabs.com/LabOnline. Enter your user ID and password provided by Aegis.
Password Change If you have not changed your password from the one provided, you can change it at the following screen. This screen will display each time you login until you change your password.
My Dashboard After login you will be at the dashboard page. This page has the menu across the top. There is a shortcut hyperlink in the lower right part of the screen that will take you to a page that displays a list of all reports that have not been viewed or downloaded. Please note that from time to time the messages and/or images on the dashboard page may change, to reflect new or updated information from the laboratory.
Configure the Samples View The donor SSN is displayed in the Description field. You need to unhide this field and arrange it next to the Sample ID field.
1. Right click on the column headers.
2. Select Display Columns from the context menu.
3. Scroll down and check the Description column.
4. Uncheck the My Workorder ID and Lab Workorder ID columns (and any other columns you do not want to see).
5. Click the OK button.
6. Click and drag the Description column so it is next to the My Sample ID column.
View Samples Clicking on the Samples tab or on the Sample Reports hyperlink will display the View Samples page. This page enables you to search for samples that were submitted to the laboratory and view reports.
The page automatically displays the past 30 days of reports. You can change the date range and/or search criteria and click the Search button to execute a new query. Choose “Everything” in the Search criteria to search all text fields for your search text. For example, the following search will display all records with “Will” in the first name or last name (case insensitive).
View a Report To view a report, click on the View hyperlink in the samples grid. When a report is viewed, the next time the grid is refreshed the Report Status will display “Read”. You can toggle this field back and forth to manage when reports are viewed by checking the rows and clicking the icon in the toolbar above the grid.
Print and/or Download Reports To print reports, check the report that you want to print and click the print icon. To download reports, check the report that you want to download and click the download icon.
Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, has launched a combined test for SARS-CoV-2 and influenza A/B virus for individuals suspected of respiratory viral infection consistent with COVID-19.
Reducing the spread of respiratory illnesses, like flu, this fall and winter is more important than ever due to the COVID-19 pandemic. Since symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar, a multiplex assay serves as a single test to diagnose infection caused by one of three viruses. Testing for all three viruses at the same time will allow for more efficient testing and diagnosis to help reduce the spread of these viruses in the community and improve patient care.
The combination COVID-19 + FLU A/B test is a reverse transcriptase polymerase chain reaction (RT-PCR) molecular test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus. Respiratory specimens are collected via nasopharyngeal, oropharyngeal, nasal mid-turbinate or anterior nares from individuals suspected of respiratory viral infection consistent with COVID-19.
